Your SlideShare is downloading. ×
The Impact of Mergers and Acquisitions on R&D Innovation and Productivity - Dr Daniel L. Mooradian, Innova Medical Design, LLC
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

The Impact of Mergers and Acquisitions on R&D Innovation and Productivity - Dr Daniel L. Mooradian, Innova Medical Design, LLC

298
views

Published on

Dr Daniel L. Mooradian, Innova Medical Design, LLC - Speaker at the marcus evans Medical Device Manufacturing Summit Fall 2012, held in Colorado Springs, delivered his presentation entitled The Impact …

Dr Daniel L. Mooradian, Innova Medical Design, LLC - Speaker at the marcus evans Medical Device Manufacturing Summit Fall 2012, held in Colorado Springs, delivered his presentation entitled The Impact of Mergers and Acquisitions on R&D Innovation and Productivity

Published in: Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
298
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Impact of M&A Activity onR&D Productivity & Innovation Daniel L. Mooradian, Ph.D. Chief Scientific Officer Innova Medical Design LLC Marcus Evans Medical Device Summit 2012 Colorado Springs, CO
  • 2. Objectives •  Mechanics of Deal making •  Discuss trends in Medical Device M&A •  Explore the Challenges facing R&D •  Share my experiences (R&D centric) as a “survivor” and student of the subject •  Invite you to share your experiences! Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 3. Introduction •  Mergers & Acquisitions are a necessary and beneficial part of the corporate “life-cycle” •  Small companies - often the preferred strategy to create investor value •  Mid-/Large-Companies - a path to growth via optimization of new or existing sales channels Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 4. Source: www.fiercemedicaldevices.com Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 5. Medical Device M&A Trends •  Strong M&A activity in the Medical Device and Biotech sector through Q2 of 2012 •  Modest activity Q3-Q4 2012 based on uncertainty regarding the election outcome, healthcare reform, etc. •  Marketplace seems poised for resurgence in 2013 Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 6. Medical Device M&A Trends •  Significant capital on the side-lines – even VCs claim to be eager to invest! •  Trend in large companies away from organic R&D •  Trend in start-ups toward strategic partnership vs. traditional VC route for start-ups Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 7. The M&A Process R&D INVOLVEMENT LOW LOW-MEDIUM HIGH xeon-international.com/services/corporate-finance/ma/the-ma-process Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 8. Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 9. Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 10. M&A Challenges •  Mandatory adoption of cumbersome processes can strain resources •  Reorganization - loss of key management, changes in reporting can impact morale •  Shift in priorities by OPS, Quality, M&S can reduce availability to support product development leading to delay Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 11. Pipeline Value/Technology •  Often an attractive sweetener during due diligence. •  The acquired may believe that they will have a new source of support for innovation •  Not the Norm. Cost of acquisition (which comes at the expense of existing businesses) makes it difficult to double down before the value of the acquisition itself has been confirmed! Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 12. Strategies to improve R&D integration Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 13. Integration Team •  Make sure you are represented on the Integration team •  Engage your functional counter-part •  Realize that everyone involved has a “day job” •  Seek opportunities for your Senior staff to participate in key integration activities •  Make integration a priority Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 14. Process Knowledge •  What is your new Innovations Process? •  What is your new company’s Budget Process? •  Who are the key decision-makers? •  Are you adequately represented? Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 15. The Deal Model •  Make sure you understand what constraints have been placed on your current and future budgets as part of the acquirers deal model •  If growth in R&D is not built into the deal model then it will be very difficult to grow post-acquisition. Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 16. Next Years Budget •  You new organization is already working on next years budget! •  You are already at a disadvantage •  Learn how budget decisions are made…… •  And who makes them! Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 17. Protect Resources •  The deal-model will set limits on unit expenditures post-acquisition •  If your needs are not reflected in the deal- model then you are at a disadvantage •  Pressure on OPS/Manufacturing/Quality (and Clinical) will put existing and future R&D resources at risk •  You must fight for position or risk decline Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 18. Protect Resources •  Critical R&D employees who are not protected by CIC agreements must be identified and protected via retention agreements if possible •  Protect against flight •  Promote engagement •  Reduce uncertainty and anxiety Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 19. Preserve Corporate Culture •  The post-acquisition period is one in which culture can play a critical role in guiding behavior in the face of uncertainty •  Too little emphasis is placed on the integration/assimilation of culture in mergers & acquisitions •  Repeat your core values often to yourself and others. Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 20. Communicate! Staff New Management Peers No news is NOT good news! Copyright © 2012 Daniel L. Mooradian. All Rights reserved
  • 21. Thank you! Copyright © 2012 Daniel L. Mooradian. All Rights reserved